RL Hulett：2026年第一季度全球医疗行业并购市场研究报告（英文版）（22页）.pdf

1、Healthcare M&A UpdateQ1 2026For more information on R.L Hulett or this report please visit our website at ,call us at(314)721-0607,or contact a professional listed on this page.REPORT HIGHLIGHTS In Q1,the S&P 500 Healthcare Industry Index decreased by 5.7%and was outperformed a 4.8%decrease in the S

2、&P over the same period.The median EV/EBITDA multiple for reported private equity deals in the Healthcare sector decreased to 10.7x in Q1 from 15.4x in 2025,but increased for strategic deals to 13.4x from 9.0 x in the prior year.M&A deal volume in the sector decreased 4.6%in Q1 to 829 deals from 869

3、 in Q4,but increased 1.6%from 816 deals in Q1 of the prior year.North America was the most active region in Q1 with 436 deals.Most notably in North America was Waters$17.5B acquisition of BD Solutions,a New Jersey-based operator of biosciences and diagnostic solutions,in February 2026.Total capital

4、invested in M&A transactions decreased 15.4%in Q1 to$93.2B from$110.1B in Q4,primarily due to fewer mega-sized deals in Q1.In Q4,Abbott acquired Exact Sciences for$21.0B while the largest deal reported in Q1 was Waters$17.5B acquisition of BD Solutions.REPORT CONTRIBUTORSCONTENTS3 Global Deal Analyt

5、ics7 Valuation Multiples10 Leading M&A Deals13 Industry Outlook14 About R.L.Hulett16 Selected Transactions18 Our M&A TeamTrevor HulettManaging DRyan HartmanAssociate Dax KugelmanAHealthcare M&A UpdateQ1 2026Healthcare M&A Update|Q1 2026|Page 3Source:PitchBook DataGlobal Deal Analytics4082479227Of th

6、e 829 deals in the Healthcare sector in Q1,North America was the most active with 436 deals.A notable North American deal(in addition to the BD Solutions deal mentioned on the previous page)was Novartis$11.3 billion acquisition of Avidity Biosciences,a San Diego-based developer of new RNA therapeuti